Recent advances in blood-related proteomics

Area of Science:

• Hematology
• Proteomics
• Molecular Biology

Background:

• Hematology has transitioned from descriptive to molecular diagnostics.
• Blood comprises plasma and cellular components (red blood cells, leukocytes, platelets).
• Plasma/serum is a complex fluid with thousands of identified proteins.

Purpose of the Study:

• To highlight the promise of plasma/serum proteomic analysis for disease markers.
• To illustrate the application of proteomics in understanding disease mechanisms.
• To discuss the impact of proteomics on hematology.

Main Methods:

• Advancements in mass spectrometry (MS) and protein separation techniques.
• Establishment of proteomics databases for plasma/serum.
• Proteomic analysis of blood cellular components (platelets, leukocytes, red blood cells).

Main Results:

• Identification of approximately 1500 different proteins in plasma/serum.
• Characterization of numerous potential new disease markers.
• Significant progress in understanding platelets and leukocytes through proteomics, unlike red blood cells.

Conclusions:

• Plasma/serum proteomic analysis holds enormous promise for diagnostic and prognostic markers.
• Proteomics provides valuable insights into disease mechanisms.
• The future of hematology will be significantly impacted by proteomics.